APO Research
Talk to an analyst

APO RESEARCH · REPORT

Micafungin Sodium for Injection

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Selected research

Market Structure

Global Micafungin Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025173 pages

Choose your research edition.

Industry ResearchMicafungin Sodium for Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Micafungin Sodium for Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Micafungin Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Micafungin Sodium for Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Micafungin Sodium for Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.

The key players are Astellas etc. Astellas occupied about 97% market share.

Read the full market overview

This report provides an overview of the global Micafungin Sodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Micafungin Sodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Micafungin Sodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Micafungin Sodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Micafungin Sodium for Injection Segment by Company

Astellas

Micafungin Sodium for Injection Segment by Type

50 mg Single-use Vial

100 mg Single-use Vial

Micafungin Sodium for Injection Segment by Application

Candidemia

Respiratory Mycosis

Gastrointestinal Mycosis

Micafungin Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Micafungin Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Micafungin Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Micafungin Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Micafungin Sodium for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Micafungin Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Micafungin Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Micafungin Sodium for Injection Industry Trends Table 2. Micafungin Sodium for Injection Industry Drivers Table 3. Micafungin Sodium for Injection Industry Opportunities and Challenges Table 4. Micafungin Sodium for Injection Industry Restraints Table 5. Global Micafungin Sodium for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Micafungin Sodium for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Micafungin Sodium for Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Micafungin Sodium for Injection Sales Market Share by Manufacturers Table 9. Global Micafungin Sodium for Injection Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Micafungin Sodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Micafungin Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Micafungin Sodium for Injection Manufacturers, Product Type & Application Table 13. Global Micafungin Sodium for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Micafungin Sodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 mg Single-use Vial Table 17. Major Manufacturers of 100 mg Single-use Vial Table 18. Global Micafungin Sodium for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Micafungin Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Micafungin Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Micafungin Sodium for Injection Sales Market Share by Type (2021-2026) Table 22. Global Micafungin Sodium for Injection Sales Market Share by Type (2027-2032) Table 23. Global Micafungin Sodium for Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Micafungin Sodium for Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Micafungin Sodium for Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Micafungin Sodium for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Micafungin Sodium for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Candidemia Table 29. Major Manufacturers of Respiratory Mycosis Table 30. Major Manufacturers of Gastrointestinal Mycosis Table 31. Global Micafungin Sodium for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Micafungin Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Micafungin Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Micafungin Sodium for Injection Sales Market Share by Application (2021-2026) Table 35. Global Micafungin Sodium for Injection Sales Market Share by Application (2027-2032) Table 36. Global Micafungin Sodium for Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Micafungin Sodium for Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Micafungin Sodium for Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Micafungin Sodium for Injection Revenue Market Share by Application (2021-2026) Table 40. Global Micafungin Sodium for Injection Revenue Market Share by Application (2027-2032) Table 41. Global Micafungin Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Micafungin Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Micafungin Sodium for Injection Sales Market Share by Region (2021-2026) Table 44. Global Micafungin Sodium for Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Micafungin Sodium for Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Micafungin Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Micafungin Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Micafungin Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Micafungin Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Micafungin Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Micafungin Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Micafungin Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Micafungin Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Micafungin Sodium for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Micafungin Sodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Micafungin Sodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Micafungin Sodium for Injection Revenue Market Share by Region (2021-2026) Table 62. Global Micafungin Sodium for Injection Revenue Market Share by Region (2027-2032) Table 63. Astellas Company Information Table 64. Astellas Business Overview Table 65. Astellas Micafungin Sodium for Injection Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Astellas Micafungin Sodium for Injection Product Portfolio Table 67. Astellas Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Micafungin Sodium for Injection Distributors List Table 71. Micafungin Sodium for Injection Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Micafungin Sodium for Injection Product Image Figure 2. Global Micafungin Sodium for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Micafungin Sodium for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Micafungin Sodium for Injection Sales (2021-2032) & (K Units) Figure 5. Global Micafungin Sodium for Injection Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Micafungin Sodium for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 mg Single-use Vial Image Figure 9. 100 mg Single-use Vial Image Figure 10. Global Micafungin Sodium for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Micafungin Sodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Micafungin Sodium for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Micafungin Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Micafungin Sodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Micafungin Sodium for Injection Revenue Market Share by Type (2021-2032) Figure 16. Candidemia Image Figure 17. Respiratory Mycosis Image Figure 18. Gastrointestinal Mycosis Image Figure 19. Global Micafungin Sodium for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Micafungin Sodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Micafungin Sodium for Injection Sales Market Share by Application (2021-2032) Figure 22. Global Micafungin Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Micafungin Sodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Micafungin Sodium for Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Micafungin Sodium for Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Micafungin Sodium for Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Micafungin Sodium for Injection Sales Market Share by Country (2021-2032) Figure 39. China Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Micafungin Sodium for Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Micafungin Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Micafungin Sodium for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Micafungin Sodium for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Micafungin Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Micafungin Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Micafungin Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Micafungin Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Micafungin Sodium for Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Micafungin Sodium for Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Single-use Vial
  • 100 mg Single-use Vial
Applications
  • Candidemia
  • Respiratory Mycosis
  • Gastrointestinal Mycosis
Companies covered
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Micafungin Sodium for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Micafungin Sodium for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Micafungin Sodium for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Micafungin Sodium for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Micafungin Sodium for Injection Market Dynamics
  1. 2.1 Micafungin Sodium for Injection Industry Trends
  2. 2.2 Micafungin Sodium for Injection Industry Drivers
  3. 2.3 Micafungin Sodium for Injection Industry Opportunities and Challenges
  4. 2.4 Micafungin Sodium for Injection Industry Restraints
3 Micafungin Sodium for Injection Market by Manufacturers
  1. 3.1 Global Micafungin Sodium for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Micafungin Sodium for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Micafungin Sodium for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Micafungin Sodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Micafungin Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Micafungin Sodium for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Micafungin Sodium for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Micafungin Sodium for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Micafungin Sodium for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Micafungin Sodium for Injection Tier 1, Tier 2, and Tier 3
4 Micafungin Sodium for Injection Market by Type
  1. 4.1 Micafungin Sodium for Injection Type Introduction
  2. 4.1.1 50 mg Single-use Vial
  3. 4.1.2 100 mg Single-use Vial
  4. 4.2 Global Micafungin Sodium for Injection Sales by Type
  5. 4.2.1 Global Micafungin Sodium for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Micafungin Sodium for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Micafungin Sodium for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Micafungin Sodium for Injection Revenue by Type
  9. 4.3.1 Global Micafungin Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Micafungin Sodium for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Micafungin Sodium for Injection Revenue Market Share by Type (2021-2032)
5 Micafungin Sodium for Injection Market by Application
  1. 5.1 Micafungin Sodium for Injection Application Introduction
  2. 5.1.1 Candidemia
  3. 5.1.2 Respiratory Mycosis
  4. 5.1.3 Gastrointestinal Mycosis
  5. 5.2 Global Micafungin Sodium for Injection Sales by Application
  6. 5.2.1 Global Micafungin Sodium for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Micafungin Sodium for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Micafungin Sodium for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Micafungin Sodium for Injection Revenue by Application
  10. 5.3.1 Global Micafungin Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Micafungin Sodium for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Micafungin Sodium for Injection Revenue Market Share by Application (2021-2032)
6 Global Micafungin Sodium for Injection Sales by Region
  1. 6.1 Global Micafungin Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Micafungin Sodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Micafungin Sodium for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Micafungin Sodium for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Micafungin Sodium for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Micafungin Sodium for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Micafungin Sodium for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Micafungin Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Micafungin Sodium for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Micafungin Sodium for Injection Revenue by Region
  1. 7.1 Global Micafungin Sodium for Injection Revenue by Region
  2. 7.1.1 Global Micafungin Sodium for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Micafungin Sodium for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Micafungin Sodium for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Micafungin Sodium for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Micafungin Sodium for Injection Revenue (2021-2032)
  8. 7.2.2 North America Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Micafungin Sodium for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Micafungin Sodium for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Micafungin Sodium for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Micafungin Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas
  2. 8.1.1 Astellas Company Information
  3. 8.1.2 Astellas Business Overview
  4. 8.1.3 Astellas Micafungin Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Micafungin Sodium for Injection Product Portfolio
  6. 8.1.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Micafungin Sodium for Injection Value Chain Analysis
  2. 9.1.1 Micafungin Sodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Micafungin Sodium for Injection Production Mode & Process
  6. 9.2 Micafungin Sodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Micafungin Sodium for Injection Distributors
  9. 9.2.3 Micafungin Sodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst